{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:57:26Z","timestamp":1790848646234,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41590-026-02652-x","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:03:14Z","timestamp":1789117394000},"page":"2006-2016","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ANKRD11 deficiency reprograms CD8+ T cell differentiation to enhance immunity in chronic infection and cancer"],"prefix":"10.1038","volume":"27","author":[{"given":"Wei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9427-3426","authenticated-orcid":false,"given":"Xue","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuzhu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8511-2885","authenticated-orcid":false,"given":"Fuping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0892-0181","authenticated-orcid":false,"given":"Baidong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3233-5473","authenticated-orcid":false,"given":"Minghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6626-0898","authenticated-orcid":false,"given":"Xuyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"2652_CR1","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","volume":"401","author":"WJ Jeng","year":"2023","unstructured":"Jeng, W. J., Papatheodoridis, G. & Lok, A. S. F. Hepatitis B. Lancet 401, 1039\u20131052 (2023).","journal-title":"Lancet"},{"key":"2652_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41577-021-00549-4","volume":"22","author":"M Iannacone","year":"2022","unstructured":"Iannacone, M. & Guidotti, L. G. Immunobiology and pathogenesis of hepatitis B virus infection. Nat. Rev. Immunol. 22, 19\u201332 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"2652_CR3","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1128\/JVI.02844-06","volume":"81","author":"C Boni","year":"2007","unstructured":"Boni, C. et al. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J. Virol. 81, 4215\u20134225 (2007).","journal-title":"J. Virol."},{"key":"2652_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nri.2016.69","volume":"16","author":"E-C Shin","year":"2016","unstructured":"Shin, E.-C., Sung, P. S. & Park, S.-H. Immune responses and immunopathology in acute and chronic viral hepatitis. Nat. Rev. Immunol. 16, 509\u2013523 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"2652_CR5","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","volume":"439","author":"DL Barber","year":"2006","unstructured":"Barber, D. L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682\u2013687 (2006).","journal-title":"Nature"},{"key":"2652_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41586-019-1620-6","volume":"574","author":"AP B\u00e9n\u00e9chet","year":"2019","unstructured":"B\u00e9n\u00e9chet, A. P. et al. Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming. Nature 574, 200\u2013205 (2019).","journal-title":"Nature"},{"key":"2652_CR7","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1038\/s41590-024-01928-4","volume":"25","author":"K Heim","year":"2024","unstructured":"Heim, K. et al. Attenuated effector T cells are linked to control of chronic HBV infection. Nat. Immunol. 25, 1650\u20131662 (2024).","journal-title":"Nat. Immunol."},{"key":"2652_CR8","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41577-024-01097-3","volume":"24","author":"R Thimme","year":"2024","unstructured":"Thimme, R., Bertoletti, A. & Iannacone, M. Beyond exhaustion: the unique characteristics of CD8+ T cell dysfunction in chronic HBV infection. Nat. Rev. Immunol. 24, 775\u2013776 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"2652_CR9","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1016\/j.cell.2024.05.038","volume":"187","author":"F Andreata","year":"2024","unstructured":"Andreata, F. et al. Therapeutic potential of co-signaling receptor modulation in hepatitis B. Cell 187, 4078\u20134094 (2024).","journal-title":"Cell"},{"key":"2652_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/srep33612","volume":"6","author":"M Huang","year":"2016","unstructured":"Huang, M. et al. Improved transgenic mouse model for studying HLA class I antigen presentation. Sci. Rep. 6, 33612 (2016).","journal-title":"Sci. Rep."},{"key":"2652_CR11","doi-asserted-by":"publisher","first-page":"eaau6905","DOI":"10.1126\/sciimmunol.aau6905","volume":"4","author":"Y Cheng","year":"2019","unstructured":"Cheng, Y. et al. Multifactorial heterogeneity of virus-specific T cells and association with the progression of human chronic hepatitis B infection. Sci. Immunol. 4, eaau6905 (2019).","journal-title":"Sci. Immunol."},{"key":"2652_CR12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1084\/jem.191.3.503","volume":"191","author":"AJ Sijts","year":"2000","unstructured":"Sijts, A. J. et al. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes. J. Exp. Med. 191, 503\u2013514 (2000).","journal-title":"J. Exp. Med."},{"key":"2652_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/cmi.2013.43","volume":"11","author":"D Yang","year":"2014","unstructured":"Yang, D. et al. A mouse model for HBV immunotolerance and immunotherapy. Cell. Mol. Immunol. 11, 71\u201378 (2014).","journal-title":"Cell. Mol. Immunol."},{"key":"2652_CR14","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1097\/HEP.0000000000000431","volume":"78","author":"MG Ghany","year":"2023","unstructured":"Ghany, M. G., Buti, M., Lampertico, P. & Lee, H. M. 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference Faculty. Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference. Hepatology 78, 1654\u20131673 (2023).","journal-title":"Hepatology"},{"key":"2652_CR15","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cell.2014.09.014","volume":"159","author":"RJ Platt","year":"2014","unstructured":"Platt, R. J. et al. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 159, 440\u2013455 (2014).","journal-title":"Cell"},{"key":"2652_CR16","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.cell.2018.11.044","volume":"176","author":"J Henriksson","year":"2019","unstructured":"Henriksson, J. et al. Genome-wide CRISPR screens in T helper cells reveal pervasive crosstalk between activation and differentiation. Cell 176, 882\u2013896 (2019).","journal-title":"Cell"},{"key":"2652_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 15, 554 (2014).","journal-title":"Genome Biol."},{"key":"2652_CR18","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41586-019-1821-z","volume":"576","author":"J Wei","year":"2019","unstructured":"Wei, J. et al. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy. Nature 576, 471\u2013476 (2019).","journal-title":"Nature"},{"key":"2652_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110083","volume":"37","author":"H Zhao","year":"2021","unstructured":"Zhao, H. et al. Genome-wide fitness gene identification reveals Roquin as a potent suppressor of CD8 T cell expansion and anti-tumor immunity. Cell Rep. 37, 110083 (2021).","journal-title":"Cell Rep."},{"key":"2652_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48397-9","volume":"15","author":"E Chen","year":"2024","unstructured":"Chen, E. et al. FLI1 promotes IFN-\u03b3-induced kynurenine production to impair anti-tumor immunity. Nat. Commun. 15, 4590 (2024).","journal-title":"Nat. Commun."},{"key":"2652_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.devcel.2014.11.031","volume":"32","author":"D Gallagher","year":"2015","unstructured":"Gallagher, D. et al. Ankrd11 is a chromatin regulator involved in autism that is essential for neural development. Dev. Cell. 32, 31\u201342 (2015).","journal-title":"Dev. Cell."},{"key":"2652_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48955-1","volume":"15","author":"Y Kibalnyk","year":"2024","unstructured":"Kibalnyk, Y. et al. The chromatin regulator Ankrd11 controls cardiac neural crest cell-mediated outflow tract remodeling and heart function. Nat. Commun. 15, 4632 (2024).","journal-title":"Nat. Commun."},{"key":"2652_CR23","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1093\/emboj\/cdf321","volume":"21","author":"H-P Kim","year":"2002","unstructured":"Kim, H.-P. & Leonard, W. J. The basis for TCR-mediated regulation of the IL-2 receptor alpha chain gene: role of widely separated regulatory elements. EMBO J. 21, 3051\u20133059 (2002).","journal-title":"EMBO J."},{"key":"2652_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.molimm.2018.08.009","volume":"103","author":"X Li","year":"2018","unstructured":"Li, X. et al. Prostaglandin E2 facilitates hepatitis B virus replication by impairing CTL function. Mol. Immunol. 103, 243\u2013250 (2018).","journal-title":"Mol. Immunol."},{"key":"2652_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13027-024-00593-4","volume":"19","author":"SB Sheikhrobat","year":"2024","unstructured":"Sheikhrobat, S. B. et al. Understanding lactate in the development of hepatitis B virus-related hepatocellular carcinoma. Infect. Agent. Cancer 19, 31 (2024).","journal-title":"Infect. Agent. Cancer"},{"key":"2652_CR26","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","volume":"27","author":"EJ Wherry","year":"2007","unstructured":"Wherry, E. J. et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27, 670\u2013684 (2007).","journal-title":"Immunity"},{"key":"2652_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/science.adj3020","volume":"387","author":"S Ma","year":"2025","unstructured":"Ma, S. et al. Nutrient-driven histone code determines exhausted CD8+ T cell fates. Science 387, eadj3020 (2025).","journal-title":"Science"},{"key":"2652_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12985-017-0874-6","volume":"14","author":"L Li","year":"2017","unstructured":"Li, L. et al. The dose of HBV genome contained plasmid has a great impact on HBV persistence in hydrodynamic injection mouse model. Virol. J. 14, 205 (2017).","journal-title":"Virol. J."},{"key":"2652_CR29","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.immuni.2016.10.018","volume":"45","author":"C Gerlach","year":"2016","unstructured":"Gerlach, C. et al. The chemokine receptor CX3CR1 defines three antigen-experienced CD8 T cell subsets with distinct roles in immune surveillance and homeostasis. Immunity 45, 1270\u20131284 (2016).","journal-title":"Immunity"},{"key":"2652_CR30","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.jhep.2014.10.001","volume":"62","author":"W Qasim","year":"2015","unstructured":"Qasim, W. et al. Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient. J. Hepatol. 62, 486\u2013491 (2015).","journal-title":"J. Hepatol."},{"key":"2652_CR31","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1172\/JCI120228","volume":"129","author":"K Wisskirchen","year":"2019","unstructured":"Wisskirchen, K. et al. T cell receptor grafting allows virological control of hepatitis B virus infection. J. Clin. Invest. 129, 2932\u20132945 (2019).","journal-title":"J. Clin. Invest."},{"key":"2652_CR32","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","volume":"571","author":"O Khan","year":"2019","unstructured":"Khan, O. et al. TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion. Nature 571, 211\u2013218 (2019).","journal-title":"Nature"},{"key":"2652_CR33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-019-1326-9","volume":"571","author":"F Alfei","year":"2019","unstructured":"Alfei, F. et al. TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection. Nature 571, 265\u2013269 (2019).","journal-title":"Nature"},{"key":"2652_CR34","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.immuni.2007.07.010","volume":"27","author":"NS Joshi","year":"2007","unstructured":"Joshi, N. S. et al. Inflammation directs memory precursor and short-lived effector CD8+ T cell fates via the graded expression of T-bet transcription factor. Immunity 27, 281\u2013295 (2007).","journal-title":"Immunity"},{"key":"2652_CR35","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/ni.3410","volume":"17","author":"A Xin","year":"2016","unstructured":"Xin, A. et al. A molecular threshold for effector CD8+ T cell differentiation controlled by transcription factors Blimp-1 and T-bet. Nat. Immunol. 17, 422\u2013432 (2016).","journal-title":"Nat. Immunol."},{"key":"2652_CR36","doi-asserted-by":"publisher","first-page":"6158","DOI":"10.1128\/jvi.69.10.6158-6169.1995","volume":"69","author":"LG Guidotti","year":"1995","unstructured":"Guidotti, L. G., Matzke, B., Schaller, H. & Chisari, F. V. High-level hepatitis B virus replication in transgenic mice. J. Virol. 69, 6158\u20136169 (1995).","journal-title":"J. Virol."},{"key":"2652_CR37","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.3390\/cancers14174134","volume":"14","author":"C Pi","year":"2022","unstructured":"Pi, C. et al. Reversing PD-1 resistance in B16F10 cells and recovering tumour immunity using a COX2 inhibitor. Cancers 14, 4134 (2022).","journal-title":"Cancers"},{"key":"2652_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-020-0916-2","volume":"3","author":"J Waaler","year":"2020","unstructured":"Waaler, J. et al. Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models. Commun. Biol. 3, 196 (2020).","journal-title":"Commun. Biol."},{"key":"2652_CR39","doi-asserted-by":"publisher","first-page":"eaai8593","DOI":"10.1126\/sciimmunol.aai8593","volume":"1","author":"T Wu","year":"2016","unstructured":"Wu, T. et al. The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness. Sci. Immunol. 1, eaai8593 (2016).","journal-title":"Sci. Immunol."},{"key":"2652_CR40","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","volume":"52","author":"J-C Beltra","year":"2020","unstructured":"Beltra, J.-C. et al. Developmental relationships of four exhausted CD8+ T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms. Immunity 52, 825\u2013841 (2020).","journal-title":"Immunity"},{"key":"2652_CR41","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.immuni.2019.11.002","volume":"51","author":"WH Hudson","year":"2019","unstructured":"Hudson, W. H. et al. Proliferating transitory T cells with an effector-like transcriptional signature emerge from PD-1+ stem-like CD8+ T cells during chronic infection. Immunity 51, 1043\u20131058 (2019).","journal-title":"Immunity"},{"key":"2652_CR42","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.immuni.2019.10.009","volume":"51","author":"R Zander","year":"2019","unstructured":"Zander, R. et al. CD4+ T cell help is required for the formation of a cytolytic CD8+ T cell subset that protects against chronic infection and cancer. Immunity 51, 1028\u20131042 (2019).","journal-title":"Immunity"},{"key":"2652_CR43","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1136\/gutjnl-2022-327059","volume":"72","author":"C-Y Meng","year":"2023","unstructured":"Meng, C.-Y. et al. Engineered anti-PDL1 with IFN\u03b1 targets both immunoinhibitory and activating signals in the liver to break HBV immune tolerance. Gut 72, 1544\u20131554 (2023).","journal-title":"Gut"},{"key":"2652_CR44","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.aaf2807","volume":"354","author":"KE Pauken","year":"2016","unstructured":"Pauken, K. E. et al. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade. Science 354, 1160\u20131165 (2016).","journal-title":"Science"},{"key":"2652_CR45","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1016\/j.cell.2025.03.008","volume":"188","author":"B Kalita","year":"2025","unstructured":"Kalita, B. et al. PAX translocations remodel mitochondrial metabolism through altered leucine usage in rhabdomyosarcoma. Cell 188, 2757\u20132777 (2025).","journal-title":"Cell"},{"key":"2652_CR46","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/icb.2015.44","volume":"93","author":"T Cukalac","year":"2015","unstructured":"Cukalac, T. et al. Paired TCR\u03b1\u03b2 analysis of virus-specific CD8+ T cells exposes diversity in a previously defined \u2018narrow\u2019 repertoire. Immunol. Cell Biol. 93, 804\u2013814 (2015).","journal-title":"Immunol. Cell Biol."},{"key":"2652_CR47","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1172\/JCI44752","volume":"121","author":"P Dash","year":"2011","unstructured":"Dash, P. et al. Paired analysis of TCR\u03b1 and TCR\u03b2 chains at the single-cell level in mice. J. Clin. Invest. 121, 288\u2013295 (2011).","journal-title":"J. Clin. Invest."},{"key":"2652_CR48","doi-asserted-by":"publisher","first-page":"W503","DOI":"10.1093\/nar\/gkn316","volume":"36","author":"X Brochet","year":"2008","unstructured":"Brochet, X., Lefranc, M.-P. & Giudicelli, V. IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 36, W503\u2013W508 (2008).","journal-title":"Nucleic Acids Res."},{"key":"2652_CR49","first-page":"695","volume":"2011","author":"V Giudicelli","year":"2011","unstructured":"Giudicelli, V., Brochet, X. & Lefranc, M.-P. IMGT\/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences. Cold Spring Harb. Protoc. 2011, 695\u2013715 (2011).","journal-title":"Cold Spring Harb. Protoc."},{"key":"2652_CR50","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.4049\/jimmunol.1601409","volume":"198","author":"Z Zhang","year":"2017","unstructured":"Zhang, Z. et al. Activation and functional specialization of regulatory T cells lead to the generation of Foxp3 instability. J. Immunol. 198, 2612\u20132625 (2017).","journal-title":"J. Immunol."},{"key":"2652_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"2652_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09982-5","volume":"10","author":"HS Kaya-Okur","year":"2019","unstructured":"Kaya-Okur, H. S. et al. CUT&Tag for efficient epigenomic profiling of small samples and single cells. Nat. Commun. 10, 1930 (2019).","journal-title":"Nat. Commun."},{"key":"2652_CR53","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.celrep.2019.03.083","volume":"27","author":"X Zhu","year":"2019","unstructured":"Zhu, X. et al. Noc4L-mediated ribosome biogenesis controls activation of regulatory and conventional T cells. Cell Rep. 27, 1205\u20131220 (2019).","journal-title":"Cell Rep."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02652-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02652-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02652-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:25:59Z","timestamp":1790846759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02652-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2652"],"URL":"https:\/\/doi.org\/10.1038\/s41590-026-02652-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6785364\/v1","asserted-by":"object"}]},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A provisional patent application has been filed based on the findings reported here (inventors: X. Zhou, M.L., W.X. and J.G.). The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}